Sign Up to like & get
recommendations!
0
Published in 2024 at "Advanced Science"
DOI: 10.1002/advs.202404886
Abstract: Immune checkpoint blockade (ICB) immunotherapy remains hampered by insufficient immunogenicity and a high‐lactate immunosuppressive tumor microenvironment (TME). Herein, a nanobody‐engineered NIR‐II nanoadjuvant with targeting metabolic reprogramming capability is constructed for potentiating NIR‐II photothermal‐ferroptosis immunotherapy. Specifically,…
read more here.
Keywords:
metabolism;
tumor;
coordinated nir;
nir photothermal ... See more keywords